Item 1.01. Entry into a Material Definitive Agreement.
On
The relevant terms of the Notes are set forth in the Indenture, included as
Exhibit 4.1 of the Company's Current Report on Form 8-K, filed on
The 2025 Notes will pay interest at the rate of 1.900% per annum, the 2027 Notes
will pay interest at the rate of 2.200% per annum, the 2030 Notes will pay
interest at the rate of 2.450% per annum, the 2040 Notes will pay interest at
the rate of 3.150% per annum and the 2050 Notes will pay interest at the rate of
3.375% per annum, which, in each case, shall be payable in cash semi-annually in
arrears on
In the event of a change in control triggering event, as defined in the Officer's Certificate attached hereto as Exhibit 4.2, the holders of the Notes may require the Company to purchase for cash all or a portion of their Notes at a purchase price equal to 101% of the principal amount of Notes, plus accrued and unpaid interest, if any. The descriptions of the Indenture, the Officer's Certificate and the Notes in this report are summaries and are qualified in their entirety by the terms of the Indenture, the Officer's Certificate and the Notes, respectively.
The Notes will rank equal in right of payment to all of the Company's other existing and future senior unsecured indebtedness, senior in right of payment to all of the Company's existing and future subordinated indebtedness, effectively subordinated in right of payment to all of the Company's subsidiaries' obligations (including secured and unsecured obligations) and subordinated in right of payment to the Company's secured obligations, to the extent of the assets securing such obligations.
--------------------------------------------------------------------------------
Item 9.01. Financial Statements and Exhibits.
Exhibit No. Document Description 1.1 Underwriting Agreement, datedFebruary 18, 2020 , by and among the Company andCitigroup Global Markets Inc. ,Goldman Sachs & Co. LLC ,Barclays Capital Inc. andMorgan Stanley & Co. LLC , as representatives of the several underwriters named therein. 4.1 Indenture, dated as ofMay 22, 2014 , between the Company andThe Bank of New York Mellon Trust Company , N.A., as trustee (incorporated by reference to Exhibit 4.1 toAmgen Inc.'s Current Report on Form 8-K filed onMay 22, 2014 ). 4.2 Officer's Certificate of the Company, dated as ofFebruary 21, 2020 , including forms of the Company's 1.900% Senior Notes due 2025, 2.200% Senior Notes due 2027, 2.450% Senior Notes due 2030, 3.150% Senior Notes due 2040 and 3.375% Senior Notes due 2050. 5.1 Opinion ofLatham & Watkins LLP , datedFebruary 21, 2020 . 23.1 Consent ofLatham & Watkins LLP (included in Exhibit 5.1). 104 Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document).
--------------------------------------------------------------------------------
© Edgar Online, source